We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+6.66%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$15.1B
AUM Growth
+$742M
Cap. Flow
-$196M
Cap. Flow %
-1.3%
Top 10 Hldgs %
36.33%
Holding
1,380
New
61
Increased
578
Reduced
366
Closed
37

Top Buys

Rank Stock Value
1
SPG icon
Simon Property Group
SPG
+$105M
2
SUI icon
Sun Communities
SUI
+$103M
3
IRM icon
Iron Mountain
IRM
+$96M
4
KIM icon
Kimco Realty
KIM
+$95.3M
5
MPT
Medical Properties Trust
MPT
+$80.5M

Top Sells

Rank Stock Value
1
PSA icon
Public Storage
PSA
+$213M
2
WELL icon
Welltower
WELL
+$143M
3
REXR icon
Rexford Industrial Realty
REXR
+$139M
4
DLR icon
Digital Realty Trust
DLR
+$40.5M
5
INVH icon
Invitation Homes
INVH
+$37.1M

Sector Composition

Rank Sector Weight
1 Real Estate 54.29%
2 Technology 12.23%
3 Consumer Discretionary 4.83%
4 Communication Services 4.52%
5 Healthcare 4.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WKC icon
1101
PUT
World Kinect Corp
WKC
$2.06B
$16K ﹤0.01%
+335
New +$7.98K
ARWR icon
1102
Arrowhead Research
ARWR
$12.1B
$15K ﹤0.01%
426
– –
BHM icon
1103
Bluerock Homes Trust
BHM
$34.1M
$15K ﹤0.01%
941
– –
BPMC
1104
DELISTED
Blueprint Medicines
BPMC
$15K ﹤0.01%
241
– –
GH icon
1105
Guardant Health
GH
$19B
$15K ﹤0.01%
412
– –
RNG icon
1106
PUT
RingCentral
RNG
$4.77B
$15K ﹤0.01%
908
-92
-9% -$2.83K
FOLD
1107
DELISTED
Amicus Therapeutics
FOLD
$14K ﹤0.01%
1,130
– –
RY icon
1108
Royal Bank of Canada
RY
$295B
$14K ﹤0.01%
150
– –
AXSM icon
1109
Axsome Therapeutics
AXSM
$12.1B
$13K ﹤0.01%
175
– –
OUT icon
1110
Outfront Media
OUT
$5.72B
$13K ﹤0.01%
820
– –
PRTA icon
1111
Prothena Corp
PRTA
$448M
$13K ﹤0.01%
195
– –
RARE icon
1112
Ultragenyx Pharmaceutical
RARE
$2.56B
$13K ﹤0.01%
282
– –
VIR icon
1113
Vir Biotechnology
VIR
$1.49B
$13K ﹤0.01%
535
– –
RETA
1114
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$13K ﹤0.01%
126
– –
CYTK icon
1115
Cytokinetics
CYTK
$10.8B
$12K ﹤0.01%
381
– –
PACB icon
1116
Pacific Biosciences
PACB
$432M
$12K ﹤0.01%
909
– –
PTCT icon
1117
PTC Therapeutics
PTCT
$6.25B
$12K ﹤0.01%
289
– –
AMPH icon
1118
Amphastar Pharmaceuticals
AMPH
$888M
$11K ﹤0.01%
194
– –
INSM icon
1119
Insmed
INSM
$22.6B
$11K ﹤0.01%
545
– –
KRYS icon
1120
Krystal Biotech
KRYS
$10.7B
$11K ﹤0.01%
96
– –
SAGE
1121
DELISTED
Sage Therapeutics
SAGE
$11K ﹤0.01%
239
– –
IMVT icon
1122
Immunovant
IMVT
$7.99B
$10K ﹤0.01%
520
– –
RVMD icon
1123
Revolution Medicines
RVMD
$39.1B
$10K ﹤0.01%
357
– –
XENE icon
1124
Xenon Pharmaceuticals
XENE
$6.28B
$10K ﹤0.01%
252
– –
AKRO
1125
DELISTED
Akero Therapeutics
AKRO
$9K ﹤0.01%
188
– –
43 44
45
46 47

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q2 2023 Portfolio in Review

As of Q2 2023, Daiwa Securities Group held 1,380 positions worth $15.1B, up 5.2% from $14.4B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Daiwa Securities Group's Q2 2023 filing shows 61 new, 578 increased, 366 reduced and 37 closed positions. Its largest new stake was Applovin: 95,413 shares worth $2.46M. The largest sale was Public Storage, an estimated $213M.

By sector, the portfolio is most concentrated in Real Estate at 54% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Daiwa Securities Group's largest Q2 2023 buy was Applovin: 95,413 shares worth $2.46M.
  • Daiwa Securities Group added most to Simon Property Group in Q2 2023, an estimated $105M increase.
  • Daiwa Securities Group's biggest Q2 2023 reduction was Public Storage, cutting an estimated $213M.
  • Daiwa Securities Group fully exited BWX Technologies in Q2 2023, selling an estimated $6.7M.
  • Daiwa Securities Group's ten largest holdings make up 36% of its $15.1B portfolio in Q2 2023.
  • Daiwa Securities Group opened 61 new positions and closed 37 in Q2 2023.
  • Daiwa Securities Group's portfolio value rose 5.2% quarter-over-quarter to $15.1B.

Based on Daiwa Securities Group's 13F filing for Q2 2023, filed 31 Jul 2023.